Literature DB >> 12548559

T cell recognition and therapeutic effect of a phosphorylated synthetic peptide of the 70K snRNP protein administered in MR/lpr mice.

Fanny Monneaux1, José Manuel Lozano, Manuel E Patarroyo, Jean-Paul Briand, Sylviane Muller.   

Abstract

Modifications of self antigens that occur during apoptosis might be involved in the generation of neo-antigens, which can break tolerance and induce autoimmunity. We have previously identified an epitope at residues 131-151 of the U1-70K snRNP protein, recognized by IgG antibodies and CD4+ T cells from at least two strains of lupus mice. With the aim of investigating the possible role of phosphorylation on the antigenicity of peptide 131-151 and to gain a better understanding of how this peptide can drive autoimmune response, we synthesized two peptides phosphorylated on Ser137 and 140, respectively. We show here that peptide P140 phosphorylated on Ser140 is recognized by both CD4+ T cells and antibodies from MRL/lpr mice. Furthermore, intravenous administration to lupus-prone MRL/lpr mice of P140 in saline (but not of the non-phosphorylated peptide) decreased proteinuria and anti-DNA antibody production, and significantly prolonged survival of treated mice. We further demonstrated that P140 is recognized by antibodies from lupus patients and binds to various HLA DR molecules, offering new hope for manipulating T cell response in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12548559     DOI: 10.1002/immu.200310002

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  38 in total

1.  Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.

Authors:  A G Terzoglou; J G Routsias; H M Moutsopoulos; A G Tzioufas
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

Review 2.  Oxidative Modifications in Tissue Pathology and Autoimmune Disease.

Authors:  Mei-Ling Yang; Hester A Doyle; Steven G Clarke; Kevan C Herold; Mark J Mamula
Journal:  Antioxid Redox Signal       Date:  2017-12-11       Impact factor: 8.401

Review 3.  Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.

Authors:  Morten A Karsdal; Mette J Nielsen; Jannie M Sand; Kim Henriksen; Federica Genovese; Anne-Christine Bay-Jensen; Victoria Smith; Joanne I Adamkewicz; Claus Christiansen; Diana J Leeming
Journal:  Assay Drug Dev Technol       Date:  2012-10-09       Impact factor: 1.738

4.  T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I.

Authors:  David Salem; Rebecca Subang; Masataka Kuwana; Jerrold S Levine; Joyce Rauch
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

Review 5.  Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes.

Authors:  Thomas Delong; Rocky L Baker; Jing He; Kathryn Haskins
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

Review 6.  Pharmacological regulators of autophagy and their link with modulators of lupus disease.

Authors:  Frédéric Gros; Sylviane Muller
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 7.  The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.

Authors:  Nicole H Kattah; Michael G Kattah; Paul J Utz
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

8.  HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.

Authors:  Bettina Panagiota Iliopoulou; Mireia Guerau-de-Arellano; Brigitte T Huber
Journal:  Arthritis Rheum       Date:  2009-12

Review 9.  Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects.

Authors:  Fanny Monneaux; Sylviane Muller
Journal:  Arthritis Res Ther       Date:  2009-06-30       Impact factor: 5.156

10.  Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy.

Authors:  Florence R Depontieu; Jie Qian; Angela L Zarling; Tracee L McMiller; Theresa M Salay; Andrew Norris; A Michelle English; Jeffrey Shabanowitz; Victor H Engelhard; Donald F Hunt; Suzanne L Topalian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.